Inventor
GOTTARDIS MARCO
US19 patents
⚠️ This page may combine multiple inventors who share the name “GOTTARDIS MARCO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
9 patentsUS9017655B2Apr 28, 2015
Bispecific EGFR/IGFIR binding molecules
BRISTOL MYERS SQUIBB CO36 citations97
US8343501B2Jan 1, 2013
Bispecific EGFR/IGFIR binding molecules
BRISTOL MYERS SQUIBB CO45 citations97
US9902762B2Feb 27, 2018
Multivalent fibronectin based scaffold domain proteins
BRISTOL MYERS SQUIBB CO28 citations93
US9771411B2Sep 26, 2017
Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules
BRISTOL MYERS SQUIBB CO22 citations93
US10774130B2Sep 15, 2020
Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins
BRISTOL MYERS SQUIBB CO6 citations83
US10183987B2Jan 22, 2019
Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules
BRISTOL MYERS SQUIBB CO7 citations83
US6624154B1Sep 23, 2003
Compositions and methods for treatment of hyperproliferative diseases
BRISTOL MYERS SQUIBB CO13 citations78
US10954286B2Mar 23, 2021
Bispecific EGFR/IGFIR binding molecules
BRISTOL MYERS SQUIBB CO2 citations72
US7138246B2Nov 21, 2006
Methods for identifying or screening for agents that modulate 17β-HSD3
BRISTOL MYERS SQUIBB CO1 citations45
JANSSEN PHARMACEUTICA NV
6 patentsUS11207311B2Dec 28, 2021
Method of treating prostate cancer
JANSSEN PHARMACEUTICA NV6 citations82
US12383543B2Aug 12, 2025
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61
US11992486B2May 28, 2024
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61
US11986469B2May 21, 2024
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61
US11986470B2May 21, 2024
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61
US11986468B2May 21, 2024
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61